|
|
Exchange: |
Nasdaq Small Cap |
Security
Type: |
Common |
Shares
Out: |
5,366,000 |
Market
Cap: |
7.51(M) |
Last
Volume: |
140,704 |
Avg
Vol: |
0 |
52
Week Range: |
$0.506 - $1.83 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile SELLAS Life Sciences Group is a late-stage clinical biopharmaceutical company focused on developing cancer immunotherapeutics for a range of cancer indications. Co.'s product candidates include galinpepimut-S (GPS) and nelipepimut-S (NPS). Co.'s primary product candidate, GPS, is a cancer immunotherapeutic agent licensed from Memorial Sloan Kettering Cancer Center that targets the Wilms tumor 1 protein, which is present in 20 or more cancer types. NPS is a cancer immunotherapy targeting the human epidermal growth factor receptor 2 expressing cancers.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
9,806 |
Total Sell Value |
$0 |
$0 |
$0 |
$25,516 |
Total People Sold |
0 |
0 |
0 |
3 |
Total Sell Transactions |
0 |
0 |
0 |
3 |
End Date |
2024-02-25 |
2023-11-24 |
2023-05-26 |
2022-05-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Hillsberg Sanford |
Director |
|
2014-01-30 |
4 |
S |
$5.41 |
$1,352,500 |
D/D |
(250,000) |
17,974 |
|
- |
|
Hillsberg Sanford |
Director |
|
2014-01-30 |
4 |
OE |
$1.18 |
$321,500 |
D/D |
250,000 |
267,974 |
|
- |
|
Nisi Rudolph |
Director |
|
2014-01-29 |
4 |
S |
$5.28 |
$1,320,000 |
D/D |
(250,000) |
3,500 |
|
- |
|
Nisi Rudolph |
Director |
|
2014-01-29 |
4 |
OE |
$0.72 |
$355,000 |
D/D |
250,000 |
253,500 |
|
- |
|
Ahn Mark J |
President & CEO |
|
2014-01-27 |
4 |
S |
$4.83 |
$3,848,375 |
D/D |
(796,765) |
113,764 |
|
- |
|
Ahn Mark J |
President & CEO |
|
2014-01-27 |
4 |
OE |
$0.72 |
$1,054,254 |
D/D |
796,765 |
918,529 |
|
- |
|
Kriegsman Steven A |
Director |
|
2014-01-23 |
4 |
S |
$5.92 |
$888,540 |
D/D |
(150,000) |
5,000 |
|
- |
|
Kriegsman Steven A |
Director |
|
2014-01-23 |
4 |
OE |
$1.18 |
$233,500 |
D/D |
150,000 |
155,000 |
|
- |
|
Kriegsman Steven A |
Director |
|
2014-01-22 |
4 |
S |
$6.13 |
$1,532,500 |
D/D |
(250,000) |
5,000 |
|
- |
|
Kriegsman Steven A |
Director |
|
2014-01-22 |
4 |
OE |
$0.72 |
$272,000 |
D/D |
250,000 |
255,000 |
|
- |
|
Hillsberg Sanford |
Director |
|
2014-01-17 |
4 |
S |
$6.93 |
$1,385,000 |
I/I |
(200,000) |
110,447 |
|
- |
|
Kriegsman Steven A |
Director |
|
2014-01-17 |
4 |
S |
$7.00 |
$1,400,000 |
D/D |
(200,000) |
5,000 |
|
- |
|
Kriegsman Steven A |
Director |
|
2014-01-17 |
4 |
OE |
$0.85 |
$170,000 |
D/D |
200,000 |
205,000 |
|
- |
|
Nisi Rudolph |
Director |
|
2014-01-17 |
4 |
S |
$6.90 |
$1,380,000 |
D/D |
(200,000) |
3,500 |
|
- |
|
Nisi Rudolph |
Director |
|
2014-01-15 |
4 |
OE |
$0.85 |
$203,000 |
D/D |
200,000 |
203,500 |
|
- |
|
Hillsberg Sanford |
Director |
|
2014-01-14 |
4 |
D |
$6.96 |
$170,005 |
I/I |
(24,426) |
310,447 |
|
- |
|
Hillsberg Sanford |
Director |
|
2014-01-14 |
4 |
OE |
$0.85 |
$170,000 |
I/I |
200,000 |
334,873 |
|
- |
|
Ahn Mark J |
President & CEO |
|
2013-12-31 |
4 |
A |
$1.88 |
$10,625 |
D/D |
5,656 |
113,764 |
|
- |
|
Schwartz Mark W. |
EVP & Chief Operating Officer |
|
2013-12-31 |
4 |
A |
$1.88 |
$10,625 |
D/D |
5,656 |
509,665 |
|
- |
|
Dunlap Ryan |
Principal Accounting Officer |
|
2013-12-31 |
4 |
A |
$1.88 |
$5,125 |
D/D |
2,728 |
5,343 |
|
- |
|
Hillsberg Sanford |
Director |
|
2013-12-12 |
4 |
D |
$4.19 |
$36,000 |
I/I |
(8,592) |
134,873 |
|
- |
|
Hillsberg Sanford |
Director |
|
2013-12-12 |
4 |
OE |
$0.72 |
$36,000 |
I/I |
50,000 |
143,375 |
|
- |
|
Hillsberg Sanford |
Director |
|
2013-11-12 |
4 |
GD |
$0.00 |
$0 |
I/I |
37,001 |
93,375 |
|
- |
|
Hillsberg Sanford |
Director |
|
2013-10-11 |
4 |
A |
$0.00 |
$0 |
D/D |
2,630 |
17,974 |
|
- |
|
Schwartz Mark W. |
EVP, Chief Operating Officer |
|
2013-10-11 |
4 |
A |
$0.00 |
$0 |
D/D |
7,349 |
504,009 |
|
- |
|
269 Records found
|
|
Page 5 of 11 |
|
|